ADIAL PHARMACEUTICALS, INC. Human Resources Contracts & Agreements
31 Contracts & Agreements
- Bonus & Incentive Agreements (8 contracts)
- Consulting Agreements (6)
- Employment Agreements (15)
- Separation Agreements (2)
- Employment Agreement between Adial Pharmaceuticals, Inc. and Vinah Shah, dated November 1, 2024 (Filed With SEC on November 5, 2024)
- Separation Agreement between Adial Pharmaceuticals, Inc. and Joseph Truluck, dated November 1, 2024 (Filed With SEC on November 5, 2024)
- Separation Agreement between Adial Pharmaceuticals, Inc. and Dr. Bankole Johnson, dated April 22, 2024 (Filed With SEC on April 26, 2024)
- Amendment No. 5 to the Adial Pharmaceuticals, Inc. 2017 Equity Incentive Plan (Filed With SEC on November 6, 2023)
- Amendment 6 to Employment Agreement effective as of the January 27, 2023 by and between Adial Pharmaceuticals, Inc. and William B. Stilley, III (Filed With SEC on February 1, 2023)
- Amendment No. 4 to the Adial Pharmaceuticals, Inc. 2017 Equity Incentive Plan (Filed With SEC on October 13, 2022)
- Amendment, dated September 8, 2022, to Consulting Agreement between Adial Pharmaceuticals, Inc. and Dr. Bankole A. Johnson, dated March 24, 2019, as amended on March 22, 2022 (Filed With SEC on September 13, 2022)
- Amendment to Employment Agreement, dated as of August 22, 2022, between Adial Pharmaceuticals, Inc. and William B. Stilley (Filed With SEC on August 23, 2022)
- Amendment to Employment Agreement, dated as of August 22, 2022, between Adial Pharmaceuticals, Inc. and Cary J. Claiborne (Filed With SEC on August 23, 2022)
- Amendment, dated March 22, 2022, to Consulting Agreement between Adial Pharmaceuticals, Inc. and Dr. Bankole Johnson, dated March 24, 2019 (Filed With SEC on March 28, 2022)
- Employment Agreement between Adial Pharmaceuticals, Inc. and Cary Claiborne, dated as of December 7, 2021 (Filed With SEC on December 9, 2021)
- Amendment No. 3 to the Adial Pharmaceuticals, Inc. 2017 Equity Incentive Plan (Filed With SEC on September 29, 2021)
- Amendment to Executive Employment Agreement with William B. Stilley, III, effective as of March 17, 2021 (Filed With SEC on March 22, 2021)
- Amendment to Executive Employment Agreement with Joseph Truluck, effective as of February 12, 2021 (Filed With SEC on March 22, 2021)
- Amendment to Executive Employment Agreement with William B. Stilley, III, effective as of February 12, 2021 (Filed With SEC on March 22, 2021)
- Amendment to Employment Agreement between Adial Pharmaceuticals, Inc. and Joseph Truluck, dated as of March 3, 2020 (Filed With SEC on March 6, 2020)
- Consulting Agreement between Adial Pharmaceuticals, Inc. and Dr. Bankole Johnson, dated March 24, 2019 (Filed With SEC on March 26, 2019)
- Amendment to Employment Agreement between Adial Pharmaceuticals, Inc. and Joseph Truluck, dated as of March 11, 2019 (Filed With SEC on March 14, 2019)
- Amendment to Employment Agreement between Adial Pharmaceuticals, Inc. and William Stilley, dated as of March 11, 2019 (Filed With SEC on March 14, 2019)
- Performance Bonus Plan Cancellation (Filed With SEC on April 16, 2018)
- Amendment to Consulting Agreement with Joseph Truluck dated December 1, 2017 (Filed With SEC on April 16, 2018)
- Grant Incentive Plan (Filed With SEC on April 16, 2018)
- Form of Employment Agreement to be entered into with Tomasz H. Zastawny, Ph.D (Filed With SEC on September 7, 2017)
- Form of Employment Agreement to be entered into with Joseph A. M. Truluck (Filed With SEC on September 7, 2017)
- Form of Employment Agreement to be entered into with William B. Stilley, III (Filed With SEC on September 7, 2017)
- Consulting Agreement between ADial Pharmaceuticals, LLC and Crescendo Communications, LLC Agreed to and approved June 30, 2017 (Filed With SEC on September 7, 2017)
- Consulting Agreement with Joseph Truluck dated April 25, 2016 (Filed With SEC on September 7, 2017)
- Executive Employment Agreement with William B. Stilley, III dated December 6, 2010 (Filed With SEC on September 7, 2017)
- Form of Stock Option Grant Notice, Option Agreement (Incentive Stock Option or Nonstatutory Stock Option) and Notice of Exercise under the 2017 Equity Incentive Plan (Filed With SEC on September 7, 2017)
- Form of Adial Pharmaceuticals, Inc. 2017 Equity Incentive Plan (Filed With SEC on September 7, 2017)
- Performance Bonus Plan dated April 15, 2017 (Filed With SEC on September 7, 2017)
